Daniel Schriber
Director of Investments bei Symbiotics Asset Management SA (Investment Management)
Aktive Positionen von Daniel Schriber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Symbiotics SA /Private Equity/
Symbiotics SA /Private Equity/ Investment ManagersFinance Symbiotics SA /Private Equity/ a private equity firm founded in 2011 by Roland Dominice and Vincent Dufresne. The firm headquartered in Geneva, Switzerland. | Private Equity Investor | 01.01.2006 | - |
Symbiotics Asset Management SA (Investment Management)
Symbiotics Asset Management SA (Investment Management) Investment ManagersFinance Symbiotics Asset Management SA (Investment Management) (Symbiotics-IM) is the asset management division of Symbiotics Asset Management SA, a market access platform for impact investing which is headquartered in Geneva, Switzerland. The firm was founded by Roland Dominicé in 2004 as Symbiotics SA. Symbiotics-IM creates tailored impact portfolios for institutional investors, such as pension funds, insurance companies or development finance institutions. They also work with global banks and asset managers to create private debt impact funds for their institutional, corporate and high net worth individual (HNWI) clientele. | Director of Investments | 01.01.2013 | - |
Analyst-Equity | 01.01.2006 | 01.09.2008 | |
Direktor der Forschung - Eigenkapital | 01.09.2008 | 01.01.2013 |
Karriereverlauf von Daniel Schriber
Ehemalige bekannte Positionen von Daniel Schriber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Symbiotics Asset Management SA (Research Firm)
Symbiotics Asset Management SA (Research Firm) Investment ManagersFinance Symbiotics Asset Management SA (Research Firm) (Symbiotics-Research) is the investment research division of Symbiotics Asset Management SA, a market access platform for impact investing headquartered in Geneva, Switzerland. The firm was founded by Roland Dominicé in 2004 as Symbiotics SA. Symbiotics-Research covers several financial institutions and intermediaries in various emerging and frontier markets, producing legal reviews and compliance checks, credit risk ratings, social responsibility ratings, financial and operational advisory reports, and financing capacity analysis. | Direktor der Forschung - Eigenkapital | 01.01.2006 | 02.01.2006 |
Symbiotics Research & Advisory SA | Präsident | 27.06.2011 | - |
Statistik
International
Schweiz | 5 |
Operativ
Director of Research - Equity | 2 |
President | 1 |
Private Equity Investor | 1 |
Sektoral
Finance | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Symbiotics Research & Advisory SA | Finance |
Symbiotics Asset Management SA (Research Firm)
Symbiotics Asset Management SA (Research Firm) Investment ManagersFinance Symbiotics Asset Management SA (Research Firm) (Symbiotics-Research) is the investment research division of Symbiotics Asset Management SA, a market access platform for impact investing headquartered in Geneva, Switzerland. The firm was founded by Roland Dominicé in 2004 as Symbiotics SA. Symbiotics-Research covers several financial institutions and intermediaries in various emerging and frontier markets, producing legal reviews and compliance checks, credit risk ratings, social responsibility ratings, financial and operational advisory reports, and financing capacity analysis. | Finance |
Symbiotics SA /Private Equity/
Symbiotics SA /Private Equity/ Investment ManagersFinance Symbiotics SA /Private Equity/ a private equity firm founded in 2011 by Roland Dominice and Vincent Dufresne. The firm headquartered in Geneva, Switzerland. | Finance |
Symbiotics Asset Management SA (Investment Management)
Symbiotics Asset Management SA (Investment Management) Investment ManagersFinance Symbiotics Asset Management SA (Investment Management) (Symbiotics-IM) is the asset management division of Symbiotics Asset Management SA, a market access platform for impact investing which is headquartered in Geneva, Switzerland. The firm was founded by Roland Dominicé in 2004 as Symbiotics SA. Symbiotics-IM creates tailored impact portfolios for institutional investors, such as pension funds, insurance companies or development finance institutions. They also work with global banks and asset managers to create private debt impact funds for their institutional, corporate and high net worth individual (HNWI) clientele. | Finance |
- Börse
- Insiders
- Daniel Schriber
- Erfahrung